Pharmacy World & Science

, Volume 32, Issue 3, pp 343–346

Knowledge and attitudes of American pharmacists concerning sulfonamide allergy cross-reactivity

  • Geoffrey C. Wall
  • Jane E. DeWitt
  • Sally Haack
  • Anisa Fornoff
  • Darla K. Eastman
  • Carrie F. Koenigsfeld
Short Research Report

Abstract

Objective Pharmacists are commonly confronted with patients with a history of sulfonamide allergy. Basic immunologic and clinical data suggest a low likelihood of a patient with a history of sulfonamide hypersensitivity developing an allergic reaction to a non-antimicrobial sulfonamide drug. We conducted a survey to describe the knowledge and attitudes of licensed pharmacists concerning sulfonamide allergy cross-reactivity. Methods A survey instrument was developed and sent to all licensed pharmacists in the state of Iowa. The survey recorded demographic information and included six patient scenarios designed to elicit responses concerning sulfonamide allergy cross-reactivity with a number of non-antimicrobial sulfonamides. Results A total of 421 surveys were returned for a 39% response rate. There was a wide discrepancy in approaches to patients with a history of sulfonamide allergy prescribed a sulfonamide containing non-antibiotic. Differences depended on previous history of tolerating the medication in question, the degree of cautionary statements in product literature, and the familiarity the pharmacist had with the product. Conclusion Our survey suggests a significant diversity in knowledge and attitudes of pharmacists concerning cross-reactivity of sulfonamide antimicrobials and other drugs with a sulfonamide moiety. Depth of training in this area may be an associative factor.

Keywords

Allergy Cross-reactivity Pharmacist behavior Sulfonamide United States 

References

  1. 1.
    Joint Commission. Sentinel Event Policy and Procedures. July 2007. http://www.jointcommission.org/NR/rdonlyres/F84F9DC6-A5DA-490F-A91F-A9FCE26347C4/0/SE_chapter_july07.pdf. Accessed 5 Dec 2009.
  2. 2.
    Demoly P, Gomes ER. Drug hypersensitivities: definition, epidemiology and risk factors. Eur Ann Allergy Clin Immunol. 2005;37:202–6.PubMedGoogle Scholar
  3. 3.
    Farrell J, Naisbitt DJ, Drummond NS, et al. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J Pharmacol Exp Ther. 2003;306:229–37.CrossRefPubMedGoogle Scholar
  4. 4.
    Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565–71.CrossRefPubMedGoogle Scholar
  5. 5.
    Patterson R, Bellow AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther. 1999;21:2065–79.CrossRefPubMedGoogle Scholar
  6. 6.
    Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antimicrobials and sulfonamide nonantimicrobials. N Engl J Med. 2003;349:1628–35.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Geoffrey C. Wall
    • 1
  • Jane E. DeWitt
    • 1
  • Sally Haack
    • 1
  • Anisa Fornoff
    • 1
  • Darla K. Eastman
    • 1
  • Carrie F. Koenigsfeld
    • 1
  1. 1.Drake University College of PharmacyDes MoinesUSA

Personalised recommendations